Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >MediSan >Year 2014, Issue 11

Rodríguez FZ, Jean-Louis B, Casaus PA, Joubert ÁG, Falcón VGC
Interval free of disease in patients with recurrent colon cancer
MediSan 2014; 18 (11)

Language: Español
References: 20
Page: 1499-1507
PDF: 318.04 Kb.

[Full text - PDF]


A descriptive study of 37 operated patients of colon cancer with healing intention and who presented tumoral recurrence, assisted in "Saturnino Lora Torres" Teaching Clinical Surgical Provincial Hospital, in Santiago de Cuba was carried out during the period 2006-2012, aimed at identifying the factors associated with the interval free of disease after the initial surgery. The affected patients older than 65 years, female sex; a primary tumour located in the right colon with postoperative stage III and II, localregional recurrence as that of greater frequency and a palpable tumour as the most common, prevailed in the case material. The clinical method, echography and colon xray for enema were decisive for the diagnosis. The exeresis of the colon cancer associated with the adjuvant chemotherapy guaranteed a longer interval free of disease, although the diagnosis of recurrence was in correspondence with the early detection during the postoperative period, the surgery was essentially palliative.

Key words: recurrent colon cancer, recurrence or relapse, postoperative follow up, surgery, chemotherapy, radiotherapy, immunotherapy, interval free of disease, secondary health care.


  1. Hano García OM, Wood Rodríguez L, Villa Jiménez OM. Caracterización clínicoepidemiológica y endoscópica en pacientes con cáncer colorrectal. Rev Cubana Med. 2010;49(1):7-16.

  2. Gómez A, Serrano R, Aranda E. Cáncer de colon. Rev Med. 2005; 9(25):1621-7.

  3. García Gutiérrez A. Enfermedades quirúrgicas del abdomen. Cáncer de colon y recto. En: García Gutiérrez A, Pardo Gómez G, Abraham Arap JF, Adefna Pérez RI, Arce Bustabad S, Barrero Soto R, et al. Cirugía. t3. La Habana: Editorial Ciencias Médicas; 2007. p. 1277-1318.

  4. Rovelo Lima JE, Rodríguez Wong U, Badillo Bravo A, Meza Sánchez JC. Escrutinio en el cáncer de colon y recto. Rev Mex Coloproctol. 2007; 13(1):20-3.

  5. Greene FL, Compton CC, Fritz AG. Colon and rectum. In: Cancer Staging Atlas. American Joint Committee on Cancer. New York: Springer; 2006:107-17.

  6. Cancer Guidelines. National Comprehensive Cancer Network (NCCN). National Cancer Institute (NCI) 2005 [citado 28 Mar 2012].

  7. González-Rodiles Heredia RE, Rodríguez Fernández Z, Casaus Prieto A. Cáncer de colon recurrente: diagnóstico y tratamiento. Rev Cubana Cir. 2009 [citado 8 Ene 2010]; 48(1).

  8. Rodríguez Fernández Z, González-Rodiles Heredia RE, Casaus Prieto A. Cáncer de colon recurrente: consideraciones actuales. Rev Cubana Cir. 2009[citado 8 Ene 2010]; 48(1).

  9. NIH Consensus Conference Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990; 264(11):1444-50.

  10. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery. 1991;110(1):13-29.

  11. Wagman LD, Kemeny MM, Leong L. A prospective, randomized evaluation of the treatment of colorectal cancer recurrence. J Clin Oncol. 2000;8(11):1885-93.

  12. Marcuello E. Seguimiento postoperatorio de los pacientes con cáncer colorrectal. Gastroenterol Hepatol. 2000; 15:66-76.

  13. Bruinvels DJ, Stiggelbout AM, Kievit J, Van Houwelingen HC, Habbema JD, Van de Velde CJ. Follow-up of patients with colorectal cancer A meta-analysis. Ann Surg. 1994; 219(2):174-82.

  14. Heidenreich A. Seguimiento postoperatorio en el carcinoma colorrectal. Rev Argent Coloproctol. 2001; 12(1):55-7.

  15. Tournigand C, André T, Achille E. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004; 22(2):229-37.

  16. Rothenberg ML, Oza AM, Burger B. Final results of a phase III trial of 5- FU/leucovorin versus oxaliplatin versus the combination in patients with metastatic colorectal cancer following irinotecan, 5-FU, and leucovorin. Proc Am Soc Clin Oncol. 2003; 22:A-1011.

  17. Martínez Ramos D, Escrig Sos J, Miralles Tena JM, Rivadulla Serrano MI, Dároca José JM, Salvador Sanchís JL. Influencia de la especialización del cirujano tras cirugía por cáncer de colon Utilidad de los índices de propensión. Rev Esp Enferm Dig. 2008; 100(7):387-92.

  18. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Local recurrence following curative surgery for large bowel cancer: I. The overall picture. Br J Surg. 1984; 71(1):17-20.

  19. Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001; 221(1):159-66.

  20. Ravikumar TS. Interstitial therapies for liver tumors. Surg Oncol Clin N Am. 1996; 5(2):365-77.

>Journals >MediSan >Year 2014, Issue 11

· Journal Index 
· Links 

Copyright 2019